Rosenkrantz Andrew B, Mannelli Lorenzo, Kim Sungheon, Babb James S
Department of Radiology, NYU Langone Medical Center, New York, NY 10016, USA.
J Comput Assist Tomogr. 2011 Jan-Feb;35(1):96-101. doi: 10.1097/RCT.0b013e3181f3d57e.
To compare image quality and lesion detection in postcontrast liver magnetic resonance imaging (MRI) between volumetric interpolated breath-hold examination (VIBE) sequences that achieve fat suppression via chemically selective fat saturation (FS-VIBE) and a 2-point Dixon water-fat separation method (Dixon-VIBE).
Thirty patients underwent contrast-enhanced liver MRI at 1.5 T in which Dixon-VIBE was performed immediately after a delayed FS-VIBE. Two radiologists in consensus reviewed the sequences for a variety of qualitative and quantitative image quality measures and for lesion detection.
Dixon-VIBE received nearly perfect scores for strength and homogeneity of fat suppression that were significantly better than scores for FS-VIBE, with an associated significant improvement in liver-fat contrast (P < 0.0001 for all comparisons). Dixon-VIBE also received significantly better scores for sharpness of intrahepatic vessels (P = 0.0029) and overall image quality (P < 0.0001). Despite a slightly longer acquisition time for Dixon-VIBE, there was no significant difference in motion artifact (P = 0.3877). There was no significant difference for sensitivity, positive predictive value, or contrast relative to background liver for focal lesions (P = 0.448, P = 0.347, and P = 0.2312, respectively).
For postcontrast liver MRI, Dixon-VIBE demonstrated significantly improved fat suppression. Various assessments of lesion detection showed no significant difference between sequences.
比较在肝脏对比增强磁共振成像(MRI)中,通过化学选择性脂肪饱和实现脂肪抑制的容积内插屏气检查(VIBE)序列(FS-VIBE)和两点 Dixon 水脂分离方法(Dixon-VIBE)的图像质量和病变检测情况。
30 例患者在 1.5T 设备上接受肝脏对比增强 MRI 检查,在延迟的 FS-VIBE 序列后立即进行 Dixon-VIBE 序列扫描。两位放射科医生共同对序列进行多种定性和定量图像质量指标以及病变检测的评估。
Dixon-VIBE 在脂肪抑制强度和均匀性方面获得了近乎完美的分数,显著优于 FS-VIBE 的分数,同时肝脏-脂肪对比度也有显著改善(所有比较 P < 0.0001)。Dixon-VIBE 在肝内血管清晰度(P = 0.0029)和整体图像质量(P < 0.0001)方面也获得了显著更高的分数。尽管 Dixon-VIBE 的采集时间略长,但运动伪影方面无显著差异(P = 0.3877)。对于局灶性病变,在敏感性、阳性预测值或相对于背景肝脏的对比度方面无显著差异(分别为 P = 0.448、P = 0.347 和 P = 0.2312)。
对于肝脏对比增强 MRI,Dixon-VIBE 显示出显著改善的脂肪抑制效果。各种病变检测评估显示序列之间无显著差异。